CIK 0001376339
- Large accelerated filer
MIMEDX GROUP, INC.
Sign in to watch- Ticker
- MDXG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 262792552
- Phone
- +1 770-651-9100
- Business address
- 1775 W OAK COMMONS COURT, NE, MARIETTA, GA, 30062
- Former names
- Alynx, Co.
- 4 Grant or award Chief Operating Officer acquired 58,478 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 58,478 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 30,764 shares at an average $8.04 ($247,426)
- 4 Open-market sale Chief Operating Officer sold 31,043 shares at an average $8.05 ($249,763)
- 4 Conversion 10% owner acquired 28,195,249 shares (conversion)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $7.16 ($35,787)
- 4 Grant or award Chief Financial Officer acquired 97,200 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 100,000 shares at an average $6.40 ($640,434)
- 4 Grant or award Director acquired 35,354 shares (grant or award)
- 4 Grant or award Director acquired 35,354 shares (grant or award)
- 4 Grant or award Director acquired 35,354 shares (grant or award)
- 4 Grant or award Director acquired 35,354 shares (grant or award)
- 4 Grant or award Director acquired 35,354 shares (grant or award)
- 4 Grant or award Director acquired 35,354 shares (grant or award)
- 4 Grant or award Director acquired 35,354 shares (grant or award)
- 4 Open-market sale President, Regenerative Med. sold 13,972 shares at an average $6.00 ($83,798)
- 4 Open-market sale General Counsel and CAO sold 5,870 shares at $5.93 ($34,786)
- 4 Open-market sale President, Regenerative Med. sold 5,869 shares at $5.93 ($34,780)
- 4 Open-market sale Chief Accounting Officer sold 1,595 shares at $5.93 ($9,452)
Page 4 of 30 · 584 filings